AI's potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his Machines of Loving Grace essay, AI could "compress decades of biological progress into just a few ...

Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

Benchling is a next-gen laboratory informatics platform that is helping life science companies manage increasingly complex data workflows. GEN Edge talks to CEO/co-founder Saji Wickramasekara and ...

We spotlight trailblazers in the entrepreneurship world, exploring their groundbreaking ventures, innovative strategies, and the latest trends shaping the business landscape. Fresh new ideas and ...

We spotlight trailblazers in the entrepreneurship world, exploring their groundbreaking ventures, innovative strategies, and the latest trends shaping the business landscape. Fresh new ideas and ...

How scientists are using Benchling AI in Claude today. Building the AI ecosystem for biotech AI's potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his ...

Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- Benchling today announced a partnership with Anthropic, an AI safety ...